| The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia JD McConnell, CG Roehrborn, OM Bautista, GL Andriole Jr, CM Dixon, ... New England Journal of Medicine 349 (25), 2387-2398, 2003 | 2297 | 2003 |
| Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial WJ Catalona, AW Partin, KM Slawin, MK Brawer, RC Flanigan, A Patel, ... Jama 279 (19), 1542-1547, 1998 | 1481 | 1998 |
| Abstinence and safer sex HIV risk-reduction interventions for African American adolescents: a randomized controlled trial JB Jemmott III, LS Jemmott, GT Fong Jama 279 (19), 1529-1536, 1998 | 947 | 1998 |
| Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy AJ Stephenson, PT Scardino, MW Kattan, TM Pisansky, KM Slawin, ... Journal of clinical oncology: official journal of the American Society of …, 2007 | 885 | 2007 |
| Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy AJ Stephenson, SF Shariat, MJ Zelefsky, MW Kattan, EB Butler, BS Teh, ... Jama 291 (11), 1325-1332, 2004 | 692 | 2004 |
| Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens P Swindle, JA Eastham, M Ohori, MW Kattan, T Wheeler, N Maru, ... The Journal of urology 174 (3), 903-907, 2005 | 556 | 2005 |
| A multicenter study of [-2] pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to … WJ Catalona, AW Partin, MG Sanda, JT Wei, GG Klee, CH Bangma, ... The Journal of urology 185 (5), 1650-1655, 2011 | 429 | 2011 |
| Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging WJ Catalona, PC Southwick, KM Slawin, AW Partin, MK Brawer, ... Urology 56 (2), 255-260, 2000 | 405 | 2000 |
| Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors MW Kattan, JA Eastham, TM Wheeler, N Maru, PT Scardino, ... The Journal of urology 170 (5), 1792-1797, 2003 | 395 | 2003 |
| Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer JL Gore, SF Shariat, BJ Miles, D Kadmon, N Jiang, TM Wheeler, ... The Journal of urology 165 (5), 1554-1559, 2001 | 303 | 2001 |
| Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer M Ohori, MW Kattan, H Koh, N Maru, KM Slawin, S Shariat, M Muramoto, ... The Journal of urology 171 (5), 1844-1849, 2004 | 296 | 2004 |
| Survivin expression is associated with features of biologically aggressive prostate carcinoma SF Shariat, Y Lotan, H Saboorian, SM Khoddami, CG Roehrborn, ... Cancer 100 (4), 751-757, 2004 | 285 | 2004 |
| Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis SF Shariat, B Andrews, MW Kattan, JH Kim, TM Wheeler, KM Slawin Urology 58 (6), 1008-1015, 2001 | 267 | 2001 |
| Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis SF Shariat, CG Roehrborn, JD McConnell, S Park, N Alam, TM Wheeler, ... Journal of Clinical Oncology 25 (4), 349-355, 2007 | 253 | 2007 |
| Baseline factors as predictors of clinical progression of benign prostatic hyperplasia in men treated with placebo ED Crawford, SS Wilson, JD McConnell, KM Slawin, MC Lieber, JA Smith, ... The Journal of urology 175 (4), 1422-1427, 2006 | 246 | 2006 |
| A precursor form of prostate-specific antigen is more highly elevated in prostate cancer compared with benign transition zone prostate tissue SD Mikolajczyk, LS Millar, TJ Wang, HG Rittenhouse, LS Marks, W Song, ... Cancer research 60 (3), 756-759, 2000 | 242 | 2000 |
| The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with … MW Kattan, SF Shariat, B Andrews, K Zhu, E Canto, K Matsumoto, ... Journal of Clinical Oncology 21 (19), 3573-3579, 2003 | 236 | 2003 |
| “BPSA,” a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasia SD Mikolajczyk, LS Millar, TJ Wang, HG Rittenhouse, RL Wolfert, ... Urology 55 (1), 41-45, 2000 | 233 | 2000 |
| Preoperative plasma levels of transforming growth factor beta1 (TGF-β1) strongly predict progression in patients undergoing radical prostatectomy SF Shariat, M Shalev, A Menesses-Diaz, IY Kim, MW Kattan, TM Wheeler, ... Journal of Clinical Oncology 19 (11), 2856-2864, 2001 | 222 | 2001 |
| Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy AK Leventis, SF Shariat, MW Kattan, EB Butler, TM Wheeler, KM Slawin Journal of clinical oncology 19 (4), 1030-1039, 2001 | 213 | 2001 |
Shahrokh F. Shariat, M.D.Department of Urology, Comprehensive Cancer Center, Medical University of Vienna and GeneralVerified email at meduniwien.ac.at
